Hence, our results point the way for more extensive investigations about cfRNAs role as biomarkers of nusinersen effect, and highlight the implication of the discussed molecular pathways in SMA pathogenesis, and their modulation after SMN2-targeting. Here, SMN2 is linked to proximal spinal muscular atrophy.